Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Blood Protein NfL Predicts Cognitive Decline and Death Risk in CentenariansLongevity & Aging

Blood Protein NfL Predicts Cognitive Decline and Death Risk in Centenarians

A study of nearly 500 Japanese centenarians found that neurofilament light chain (NfL), a protein released into the blood when nerve cells are damaged, is a powerful predictor of both cognitive decline and death risk in people over 100. Those with higher NfL levels scored worse on memory and thinking tests and faced a 36% higher risk of dying during the follow-up period. Importantly, NfL outperformed classic Alzheimer's biomarkers like amyloid and tau in predicting mortality, suggesting it reflects broader nervous system and body-wide health rather than just Alzheimer's disease pathology. These findings, replicated across Danish and Japanese cohorts, position NfL as a promising universal aging biomarker.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.